ID

28842

Description

Study ID: 100723 Clinical Study ID: AXR100723 Study Title: A 24 Week Randomized, Double-blind, Double-dummy, Multicenter Study to Compare the Efficacy of Formulation X and AVANDIA™ (8mg OD) in Subjects with Type 2 Diabetes Mellitus Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia; Avandia XR; Avandia XR,Rosiglitazone XR,Avandia; Rosiglitazone XR Study Indication: Diabetes Mellitus, Type 2 Documentation part: Pre-Screening - Visit 1

Mots-clés

Versions (1)
  1. 08/02/2018 08/02/2018 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

8 février 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Efficacy of Formulation X and AVANDIA in Subjects with Type 2 Diabetes Mellitus 100723

Anglais

Pre-Screening - Visit 1

1 Formulaires  
Subject Eligibility for Continuation
Description

Subject Eligibility for Continuation

Alias
UMLS CUI-1
C2348568
UMLS CUI-2
C0805733
UMLS CUI-3
C0013893
Center
Description

Center

Type de données

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Subject ID
Description

Subject ID

Type de données

text

Alias
UMLS CUI [1]
C2348585
Initials
Description

Initials

Type de données

text

Alias
UMLS CUI [1]
C2986440
Visit Date
Description

Visit Date

Type de données

date

Alias
UMLS CUI [1]
C1320303
I f known, record local lab HbA1c value drawn within 6 weeks prior to Pre-Screening visit
Description

HbA1c

Type de données

float

Unités de mesure
  • %
Alias
UMLS CUI [1]
C0019018
%
Based upon their prior diabetes therapy does the subject meet one of the following HbA1c criteria? - Drug Naïve and HbA1c > = 7.5 and < = 11% - Oral antidiabetic monotherapy and HbA1c > = 7 and < = 10% - Oral antidiabetic combinationtherapy and HbA1c > = 6.5 and < = 10%
Description

HbA1c Criteria

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019018
UMLS CUI [1,2]
C1516637
I f 'No', select the criteria that was not met.
Description

HbA1c criteria that was not met

Type de données

integer

Alias
UMLS CUI [1,1]
C0019018
UMLS CUI [1,2]
C1516637
Were lab samples obtained?
Description

lab samples

Type de données

boolean

Alias
UMLS CUI [1]
C0005834
UMLS CUI [2]
C0005834
Date Sample Taken
Description

Date Sample Taken

Type de données

date

Alias
UMLS CUI [1]
C1302413
Retour au début de la page

Similar models

Pre-Screening - Visit 1

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Subject Eligibility for Continuation
C2348568 (UMLS CUI-1)
C0805733 (UMLS CUI-2)
C0013893 (UMLS CUI-3)
Center
Item
Center
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Initials
Item
Initials
text
C2986440 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
HbA1c
Item
I f known, record local lab HbA1c value drawn within 6 weeks prior to Pre-Screening visit
float
C0019018 (UMLS CUI [1])
HbA1c Criteria
Item
Based upon their prior diabetes therapy does the subject meet one of the following HbA1c criteria? - Drug Naïve and HbA1c > = 7.5 and < = 11% - Oral antidiabetic monotherapy and HbA1c > = 7 and < = 10% - Oral antidiabetic combinationtherapy and HbA1c > = 6.5 and < = 10%
boolean
C0019018 (UMLS CUI [1,1])
C1516637 (UMLS CUI [1,2])
Item
I f 'No', select the criteria that was not met.
integer
C0019018 (UMLS CUI [1,1])
C1516637 (UMLS CUI [1,2])
HbA1c criteria that was not met
Code List
I f 'No', select the criteria that was not met.
CL Item
Drug Naïve and HbA1c > = 7.5 and < = 11% (1)
CL Item
Oral antidiabetic monotherapy and HbA1c > = 7 and < = 10%  (2)
CL Item
Oral antidiabetic combinationtherapy and HbA1c > = 6.5 and < = 10% (3)
lab samples
Item
Were lab samples obtained?
boolean
C0005834 (UMLS CUI [1])
C0005834 (UMLS CUI [2])
Date Sample Taken
Item
Date Sample Taken
date
C1302413 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial